Related by context. All words. (Click for frequent words.) 72 ACE Inhibitors 72 Topiramate 72 Dasatinib 72 Interferon Beta 72 Monotherapy 71 Abatacept 71 Meets Primary Endpoint 71 Bosutinib 71 Disease Progression 71 Carvedilol 71 Adjuvant Treatment 71 Danazol 71 Aliskiren 71 metastatic malignant 70 CYP#A# inhibitors 70 Capecitabine 70 SPRYCEL ® 70 Tacrolimus 70 angiotensin receptor blocker ARB 70 Benign Prostatic Hyperplasia 70 BANZEL 70 lamotrigine Lamictal 70 mycophenolate mofetil 70 MULTAQ 70 Is Well Tolerated 70 Carbidopa 70 Pemetrexed 70 Fondaparinux 70 Cardiotoxicity 70 Vidaza azacitidine 70 Patients Receiving 70 Posaconazole 70 Lamotrigine 70 Decitabine 70 Montelukast 70 Nebulized 70 Natalizumab 70 sorafenib Nexavar 70 Bortezomib 70 Oral Fingolimod 69 Angiotensin Converting Enzyme 69 Oral Formulation 69 Hepatic Encephalopathy 69 Ziprasidone 69 Mg Uk 69 Bevacizumab 69 Lenalidomide 69 Adjunctive 69 LYSTEDA 69 Tiotropium 69 ritonavir boosted 69 Fludarabine 69 Phase IIb Trial 69 Azacitidine 69 Teriflunomide 69 ZOLINZA 69 haloperidol Haldol 69 ORENCIA ® 69 diabetic gastroparesis 69 Interferon beta 1a 69 Severe Sepsis 69 Statistically Significant 69 adalimumab Humira 69 Receptor Antagonists 69 dual endothelin receptor antagonist 69 thalidomide Thalomid 69 Hypercholesterolemia 69 Safinamide 69 esomeprazole Nexium 69 chronic thromboembolic pulmonary 69 Ranolazine 69 Fingolimod 69 Novel Oral 69 Fulvestrant 69 Pioglitazone 69 sitaxsentan 69 Cyclooxygenase 2 69 Atomoxetine 69 Patients Treated With 69 Gefitinib 69 Aurora Kinase 69 Cilostazol 69 Combination Therapy 69 candesartan cilexetil 69 Bronchodilator 69 Advanced Melanoma 69 Improve Survival 69 Well Tolerated 69 gefitinib Iressa 69 Antipsychotic 69 CYT# QbG# 69 Adalimumab 69 Hormone Refractory Prostate Cancer 68 Prolongs Survival 68 Infliximab 68 Hydroxyurea 68 Adjuvant Therapy 68 angiotensin converting enzyme inhibitors 68 Mg Usa 68 Phase 2b Study 68 icatibant 68 FASLODEX 68 Erlotinib 68 Inhaled Corticosteroids 68 Diuretic 68 Fibrates 68 Demonstrated Significant 68 paroxetine Paxil 68 Phase 2b Clinical Trial 68 Telithromycin 68 Glatiramer acetate 68 Degarelix 68 Combination Treatment 68 mecamylamine 68 Peginterferon Alfa 2a 68 Naive Patients 68 mycophenolic acid 68 docetaxel Taxotere ® 68 Antitumor Activity 68 Fluticasone 68 leukotriene receptor antagonist 68 diclofenac Voltaren 68 GW# [003] 68 Nilotinib 68 uricase 68 Pramlintide 68 beta 1a 68 long acting bronchodilator 68 Bicalutamide 68 Tigecycline 68 IND Application 68 RhuDex 68 BENICAR HCT 68 sertraline Zoloft 68 Investigational Compound 68 Interferon beta 1b 68 pyridostigmine 68 CIMZIA TM certolizumab pegol 68 Tyrosine Kinase Inhibitor 68 Indacaterol 68 Drug Candidate 68 Mitoxantrone 68 Tasimelteon 68 Toremifene 68 salmeterol fluticasone 68 Vandetanib 68 Complicated Skin 68 Phase 2a Clinical Trial 68 Sprycel dasatinib 68 Newly Diagnosed Multiple Myeloma 68 ® lenalidomide 68 levetiracetam Keppra 68 Denufosol 68 rufinamide 68 Clinical Trial Results 68 R lenalidomide 68 Phase III Clinical Trial 68 PEG IFN 68 Exemestane 68 Initiate Clinical Trial 68 Irinotecan 67 Omalizumab 67 Treating Chronic 67 See CLINICAL PHARMACOLOGY 67 acarbose 67 Teriparatide 67 Inhalation Solution 67 dasatinib Sprycel 67 HMG CoA reductase inhibitors 67 Aflibercept 67 etanercept Enbrel 67 Pulmonary Arterial Hypertension 67 Investigational Treatment 67 VAPRISOL 67 Pregabalin 67 topiramate Topamax 67 Replacement Therapy 67 Helicobacter pylori eradication 67 Etanercept 67 Vimpat R 67 Refractory Hodgkin Lymphoma 67 Pharmacokinetics PK 67 Immunosuppression 67 abacavir Ziagen 67 SPIRIVA ® 67 RISPERDAL ® 67 Improves Outcomes 67 Zyban bupropion 67 Azathioprine 67 colesevelam HCl 67 Noxafil 67 FDA Approvals 67 glatiramer acetate 67 anticholinergic agents 67 pregabalin Lyrica 67 AZILECT R 67 corticosteroid therapy 67 MAGE A3 ASCI 67 Abacavir 67 recurrent glioblastoma multiforme 67 infliximab Remicade 67 imipramine Tofranil 67 riociguat 67 primidone 67 MAXALT 67 Peripheral Arterial 67 lapatinib Tykerb 67 overactive bladder symptoms 67 divalproex sodium 67 Parnate 67 Adjunctive Therapy 67 Heart Failure Patients 67 Fluconazole 67 TLK# 67 Dupuytren Contracture 67 Eszopiclone 67 Carbamazepine 67 Primary Hypercholesterolemia 67 ATACAND 67 Improved Survival 67 Orally Active 67 efalizumab 67 Golimumab 67 Prilosec omeprazole 67 Interferon beta 67 BYSTOLIC 67 Sitagliptin 67 Overactive Bladder 67 Pegylated 67 aripiprazole Abilify 67 tocilizumab 67 Betaferon R 67 Dapagliflozin 67 RoACTEMRA 67 Relapsing Remitting Multiple Sclerosis 67 MEVACOR 67 Zoloft sertraline 67 Long Term Efficacy 67 JAK Inhibitor 67 Platinol ® 67 Myelodysplastic Syndrome MDS 67 Relapsing Multiple Sclerosis 67 hyperphenylalaninemia HPA due 67 Risperidone 67 gastrointestinal stromal tumors GIST 67 MAO inhibitor 67 Cyclosporine 67 Fluorouracil 67 pimozide 67 PEGylated Fab fragment 67 EFFEXOR XR 67 Study Evaluating 67 biliary tract cancer 67 reuptake inhibitor 67 clotrimazole 67 Melphalan 67 Phase 2b Trial 67 Sertraline 67 paricalcitol 67 Diabetic Neuropathy 67 RezularTM 67 Bupropion 67 Non Alcoholic Steatohepatitis 67 DOXIL 67 β blockers 67 Elderly Patients 67 Demonstrates Efficacy 67 Temsirolimus 67 Eltrombopag 67 Thiazolidinediones 67 Hepatic Impairment 67 oral prodrug 67 antimuscarinic 67 II Clinical Trial 67 Controlled Trial 67 Achieves Primary Endpoint 67 subependymal giant cell 67 nicardipine 67 Pegloticase 67 Plaque Psoriasis 67 Lupus Nephritis 67 Receptor Agonist 67 TNF Tumor Necrosis Factor 67 Shows Efficacy 67 sorafenib tablets 67 Imatinib 67 Treated Patients 67 Pooled Analysis 67 ibandronate 67 tiagabine 66 leukemia AML 66 Gemcitabine 66 Moxifloxacin 66 Darunavir 66 Beta Blocker 66 Schizophrenia Treatment 66 invasive candidiasis 66 Subgroup Analysis 66 Levetiracetam 66 Chemoradiation 66 Pegylated Interferon 66 Pediatric Patients 66 GlaxoSmithKline Requip 66 Cholesterol Lowering Drug 66 Zoledronic Acid 66 Bisphosphonate 66 Metastatic Prostate Cancer 66 antimetabolite 66 Clinical Trial Evaluating 66 Renal Insufficiency 66 monoamine oxidase inhibitors 66 benazepril 66 Bivalirudin 66 Allergic Rhinitis 66 Tipranavir 66 Lubiprostone 66 Inhalation Aerosol 66 myelodysplastic myeloproliferative diseases 66 Anthracycline 66 Low Dose 66 DFMO 66 NMDA antagonists 66 CYP #D# 66 xanthine oxidase inhibitor 66 Sorafenib 66 Exacerbation 66 Bayer Onyx 66 Disease Modifying 66 erlotinib Tarceva 66 Phase IIa Clinical Trial 66 Paraplatin ® 66 Ambrisentan 66 Peginterferon 66 Protease Inhibitors 66 Chronic Heart Failure 66 Demonstrates Positive 66 Trastuzumab 66 Avanafil 66 MGd 66 teriflunomide 66 Combination therapy 66 leflunomide 66 Double Blind Randomized 66 Aortic Stenosis 66 somatostatin analog 66 alefacept 66 donepezil Aricept 66 Cancidas 66 Mycophenolate Mofetil 66 pioglitazone HCl 66 treat benign prostatic 66 cis retinoic acid 66 recombinant tissue plasminogen 66 quetiapine Seroquel 66 selegiline 66 zonisamide SR 66 ß blockers 66 Nocturia 66 Pharmacokinetic Study 66 Hypertensive Patients 66 Ticagrelor 66 flutamide 66 Zileuton 66 Non Alcoholic Fatty 66 serotonin norepinephrine reuptake inhibitor 66 AMEVIVE 66 Castration Resistant Prostate Cancer 66 Nonsteroidal anti inflammatory 66 R pioglitazone HCl 66 Neoadjuvant 66 Adefovir 66 Idiopathic Pulmonary Fibrosis 66 Dabigatran 66 Ropinirole 66 Maribavir 66 Pegylated Liposomal Doxorubicin 66 Ranibizumab 66 agomelatine 66 Metastatic Melanoma 66 alfuzosin 66 nucleoside analog 66 KOMBIGLYZE XR 66 alfa 2a 66 ORENCIA R 66 Kepivance 66 Salmeterol 66 HoFH 66 bronchial hyperresponsiveness 66 antiepileptics 66 Rheumatoid Arthritis Patients 66 Chronic Sinusitis 66 FDA APPROVES 66 HER2 Positive Breast Cancer 66 pertuzumab 66 oxcarbazepine 66 Contraindications 66 TREDAPTIVE 66 Tolerability 66 Knee Osteoarthritis 66 Antiviral Therapy 66 Valsartan 66 Squalamine 66 flecainide 66 ACE Inhibitor 66 L dopa 66 Transdermal Patch 66 SYN# 66 Antiangiogenic 66 Pivotal Phase III 66 aspirin clopidogrel 66 Efficacy Trial 66 Galantamine 66 Pharmacodynamics 66 Rivaroxaban 66 neurologic progression 66 torsade de pointes 66 platelet inhibitor 66 ACTEMRA TM 66 AVAPRO 66 PEGylated anti 66 Catena ® 66 venlafaxine Effexor 66 Demonstrates Significant 66 Pazopanib 66 Placebo Controlled Study 66 Venlafaxine 66 Immunomodulatory 66 gabapentin Neurontin 66 Ramelteon 66 denileukin diftitox 66 PEGINTRON TM 66 Romidepsin 66 Fluvastatin 66 Lacosamide 66 Formoterol 66 Epidermal Growth Factor Receptor 66 ZD# [001] 66 TO AVOID PREGNANCY WHILE 66 Certolizumab pegol 66 olmesartan 66 Pelvic Organ Prolapse 66 interferon ribavirin 66 edifoligide 66 azacytidine 66 Follicular Lymphoma 66 NMDA antagonist 66 Diabetic Foot Ulcer 66 Ischemic 66 Pramipexole 66 Fracture Risk 66 cinacalcet 66 Roche Actemra 66 Anticonvulsants 66 Pafuramidine 66 diarrhea predominant irritable 66 Sapacitabine 66 Cyclophosphamide 66 Thromboembolism 66 erlotinib Tarceva ® 66 Epoetin Alfa 66 INFERGEN 66 thiazide diuretic 66 Placebo Controlled Trial 66 Extended Release 65 propranolol Inderal 65 Symptom Relief 65 triiodothyronine 65 systemic corticosteroid 65 SUTENT ® 65 angiotensin converting enzyme inhibitor 65 Cutaneous T 65 aldosterone antagonists 65 Bipolar Depression 65 LHRH agonists 65 receptor tyrosine kinase inhibitor 65 Huntexil 65 Acute Ischemic Stroke 65 phenelzine 65 Neuroprotective Effects 65 HLA DR4 65 Quetiapine 65 opioid induced bowel dysfunction 65 Antihistamine 65 Tumor Response 65 pentoxifylline 65 Zorbtive TM 65 NDA Submission 65 Varespladib 65 Renal Function 65 ribavirin USP 65 Single Dose 65 CONTRAINDICATIONS 65 Clopidogrel 65 Valproate 65 laropiprant 65 Renal Cell Carcinoma 65 ara C 65 hepatic insufficiency 65 Chronic HCV 65 nimodipine 65 ULORIC 65 Leukemias 65 relapsing multiple sclerosis 65 Vidofludimus 65 ACOMPLIA R 65 citalopram Celexa 65 antiplatelet medications 65 antithyroid 65 metformin sulfonylurea 65 Panzem R 65 Boceprevir 65 Intravenous Formulation 65 QVAR ® 65 Angioedema 65 tricyclic antidepressants TCAs 65 INTEGRILIN R 65 Femara letrozole 65 Darusentan 65 Donepezil 65 Randomized Double blind 65 Captopril 65 Nesiritide 65 rosuvastatin #mg 65 Adjuvant Chemotherapy 65 AVASTIN 65 fosbretabulin 65 Controlled Study 65 ropinirole Requip 65 Loxapine 65 oral antidiabetic medication 65 relapsed MM 65 direct thrombin inhibitors 65 clobazam 65 Vildagliptin 65 EVIZON TM 65 diabetic neuropathic pain 65 refractory chronic lymphocytic 65 Recombinant Human 65 boosted protease inhibitor 65 ergot derivatives 65 Squamous Cell Carcinoma 65 VIIBRYD 65 octreotide acetate 65 inotropic 65 Desvenlafaxine Succinate 65 transcranial Doppler ultrasound 65 Novel Compound 65 dihydrochloride 65 Medoxomil 65 Itraconazole 65 Advanced Renal Cell 65 antiarrhythmic 65 Calcitonin 65 Interferon Alfa 65 potassium sparing diuretics 65 keloid scarring 65 generation purine nucleoside 65 Radiofrequency Ablation RFA 65 antidiabetic drugs 65 mapatumumab 65 budesonide formoterol 65 Prostatic 65 irbesartan 65 Myelofibrosis 65 INVEGA ® 65 basiliximab 65 ropinirole 65 Tofranil 65 EMSAM 65 Traficet EN 65 rFVIIa 65 Treatment Regimen 65 ziprasidone Geodon 65 paroxetine sertraline 65 TYGACIL 65 Combo Therapy 65 chronic eosinophilic leukemia 65 primary hypercholesterolemia 65 platelet inhibition 65 Mouse Model 65 lovastatin Mevacor 65 Paxil paroxetine 65 Fenofibrate 65 onabotulinumtoxinA 65 CIMZIA TM 65 Sipuleucel T 65 Dalbavancin 65 CDK inhibitor 65 Shows Statistically Significant 65 Plus Ribavirin 65 eosinophilic asthma 65 dexrazoxane 65 interferon gamma 1b 65 endometrial hyperplasia 65 Chronic Hepatitis C 65 dasatinib Sprycel ® 65 Glatiramer Acetate 65 Corticosteroids 65 Desmopressin 65 Corticosteroid 65 Randomized Phase 65 lansoprazole Prevacid 65 Etravirine 65 guanfacine extended release 65 caspofungin 65 abatacept Orencia 65 antiangiogenic agent 65 SELZENTRY 65 FOLFOX6 65 sapropterin dihydrochloride 65 Paliperidone Palmitate 65 Prospective Randomized 65 Solid Tumors 65 Relapsed Refractory 65 antiandrogen 65 Rheumatoid Arthritis RA 65 Tocilizumab 65 H2 antagonists 65 Randomized Double Blind 65 liposome injection 65 systemic fungal infections 65 Muraglitazar 65 Romiplostim 65 receptor blocker 65 MIRAPEX ER 65 metastatic neuroendocrine tumors 65 hyperplasia BPH 65 Angiotensin 65 Anastrozole 65 Soft Tissue Sarcoma 65 Telmisartan 65 oral renin inhibitor 65 CYT# potent vascular disrupting 65 insulin glulisine 65 systemic hypotension 65 Granulocyte Colony Stimulating Factor 65 Proton Pump Inhibitors 65 Fludara ® 65 Phase III Trial 65 phosphodiesterase inhibitor 65 bisoprolol 65 Hypotension 65 cromolyn sodium 65 haematologic 65 TNF blocker 65 5 Fluorouracil 65 Anti Tumor 65 Diabetic Patients 65 Pertuzumab 65 Nifedipine 65 Glucocorticoid 65 ADCIRCA 65 Blood Pressure Drug 65 ACTOS ® 65 Tasigna nilotinib 65 galiximab 65 Torisel 65 HDAC Inhibitor 65 octreotide 65 Losartan 65 cilostazol 65 Epratuzumab 65 IL# PE#QQR 65 Trabectedin 65 budesonide inhalation suspension 65 anticholinergics 65 tenofovir emtricitabine 65 Partial Onset Seizures 65 Ocrelizumab 65 atorvastatin #mg 65 Secondary Hyperparathyroidism 65 ACE inhibitor ramipril 65 Efficacious 65 corifollitropin alfa 65 hypereosinophilic syndrome 65 Camptosar ® 65 Orally administered 65 Sulfonylurea 65 Vimpat lacosamide 65 inhibitor RG# 65 Parathyroid Hormone 65 Appears Safe 65 Hyperlipidemia 65 raloxifene Evista 65 Cyclosporin 65 abacavir lamivudine 65 cetuximab Erbitux R 65 iloprost 65 Epirubicin 65 topically administered 65 Eculizumab 65 zoledronate 65 Febuxostat 65 Immunosuppressant 64 efaproxiral 64 fallopian tube cancers 64 IN PATIENTS WITH 64 nonstimulant 64 bosentan 64 Sustained Release 64 Rituximab 64 Trandolapril 64 ADP receptor antagonist 64 Vaprisol 64 Oral Mucositis 64 Study Showed 64 Retreatment 64 Methylnaltrexone 64 acute GvHD 64 CIMZIA R 64 Improves Survival 64 KRN# 64 Pivotal Phase 64 Oral Cladribine 64 chronic idiopathic thrombocytopenic purpura 64 protease inhibitor PI 64 PsA 64 mGluR5 NAM 64 Intravitreal 64 Atopic Dermatitis 64 Survival Benefit 64 Estrogen Receptor 64 Kamada AAT 64 levocetirizine 64 interferon therapy 64 concomitant medications 64 NICE Recommends 64 ABC/3TC 64 Renal Impairment 64 vorinostat 64 fluvastatin Lescol 64 Metastatic Colorectal Cancer 64 HeFH 64 DDP# 64 Liposomal 64 TOVIAZ 64 Previously Treated 64 glatiramer 64 QD dosing 64 Doxil ® 64 fluvastatin 64 Heterozygous Familial Hypercholesterolemia 64 Atypical Hemolytic Uremic Syndrome 64 alteplase 64 Shows Promise Against 64 alkylating agent 64 Peginterferon alfa 2b 64 STRIDE PD 64 Diabetic Nephropathy 64 Major Depressive Disorder 64 Abciximab 64 Janssen Risperdal 64 Paroxetine 64 IFN α 64 #mg/#mg 64 tolvaptan 64 Topotecan 64 Ustekinumab 64 Systemic Lupus Erythematosus 64 complement inhibitor eculizumab 64 Myelodysplastic Syndromes 64 Hepatotoxicity 64 micafungin 64 Celecoxib 64 Vfend 64 receptor blockers 64 Certolizumab 64 trastuzumab Herceptin ® 64 Initiates Clinical Trial 64 Sandostatin R 64 administered concomitantly 64 Atherosclerotic 64 tipranavir 64 Node Positive 64 efavirenz EFV 64 mitochondrial toxicity 64 DAPT 64 tenofovir Viread 64 Progressive Multifocal Leukoencephalopathy 64 biologic DMARD 64 APTIVUS R 64 Chronic Bronchitis 64 4mg/kg 64 Patients Undergoing 64 Keppra XR 64 mycophenolate mofetil MMF 64 trimethoprim sulfamethoxazole 64 Initiate Phase 64 Disulfiram 64 glatiramer acetate GA 64 Cimetidine 64 amifostine 64 Juvenile Idiopathic Arthritis 64 terfenadine 64 Patients Treated 64 ranitidine Zantac 64 Cisplatin 64 TNF antagonist 64 lanreotide 64 Tumor Growth 64 Enzastaurin 64 Chemokine Receptor 64 palifermin 64 Dabigatran etexilate 64 memantine Namenda 64 Zarnestra 64 HuMax EGFr 64 lumiliximab 64 Malignant Glioma 64 Theophylline 64 gliclazide 64 Prophylactic Treatment 64 zafirlukast 64 Tolvaptan 64 standard chemotherapy regimen 64 fenretinide 64 moderate renal impairment 64 atrophic vaginitis 64 Aptivus ® 64 trospium 64 piperacillin tazobactam 64 benign prostatic hypertrophy BPH 64 Nucleoside 64 Squamous 64 intranasal formulation 64 acitretin 64 Vidaza ® 64 tacrolimus ointment 64 desvenlafaxine 64 Ivabradine 64 alpha blocker 64 albiglutide 64 APTIVUS r 64 idarubicin 64 octreotide LAR 64 Anti TNF 64 Pletal 64 vapreotide acetate 64 cranial irradiation 64 nitrofurantoin 64 Cinacalcet 64 anti androgen 64 CLINICAL PHARMACOLOGY 64 Telbivudine 64 nephrotoxicity 64 Fewer Side Effects 64 clomipramine 64 Zoledronic acid 64 β blocker 64 Dyloject TM 64 Mipomersen 64 Rheumatoid 64 Inhaled nitric oxide 64 Beta Blockers 64 briakinumab 64 RLAI 64 R Saizen R 64 dose dependently 64 lenalidomide Revlimid R 64 Investigational Drug 64 alendronate Fosamax 64 Biolimus A9 64 STELARA TM 64 adjunctive placebo 64 Hycamtin ® 64 Navelbine ® 64 Rotigotine 64 rivastigmine Exelon 64 AVONEX ® 64 Major Depressive Disorder MDD 64 LOVENOX R 64 DULERA 64 salmeterol inhalation powder 64 serum calcium levels 64 APTIVUS 64 Randomized Clinical Trial 64 Cloretazine 64 Lamictal XR 64 bevacizumab Avastin 64 treat chronic sinusitis 64 Hsp# Inhibitor 64 cardiac repolarization 64 Investigational Agent 64 ALGRX 64 selective phosphodiesterase 64 multikinase inhibitor 64 Cholinesterase inhibitors 64 omeprazole Prilosec 64 antiplatelet agent 64 peginterferon alpha 2a 64 clodronate 64 brand ciclesonide HFA 64 Esomeprazole 64 antiplatelet drugs 64 mixed hyperlipidemia 64 Perforomist ™ Inhalation Solution 64 budesonide pMDI 64 gemcitabine Gemzar 64 AZT zidovudine Retrovir 64 H2 blockers 64 Crestor rosuvastatin 64 cisplatin gemcitabine 64 purpura ITP 64 Mirtazapine 64 Rilonacept 64 B Cell Lymphoma 64 Hepatocellular Carcinoma 64 Gleevec resistant 64 Glufosfamide 64 Unstable Angina 64 nortriptyline Pamelor 64 Selective serotonin reuptake inhibitors 64 vasodilators 64 TRANSFORMS 64 prucalopride 64 LENALIDOMIDE 64 Mirapexin 64 BENICAR 64 Liver Injury 64 Infected Patients 64 elotuzumab 64 COREG 64 Unfractionated Heparin 64 lenalidomide dexamethasone 64 Eli Lilly Cymbalta 64 Dose Escalation Study 64 Cognitive Impairment 64 Reminyl galantamine 64 colorectal adenoma 64 Diovan HCT 64 SUSTENNA TM 64 Taxol paclitaxel 64 artery stenosis 64 thromboxane A2 64 Clinical Outcome 64 BARACLUDE ® 64 EGFR TKI 64 procainamide 64 Invasive Breast Cancer 64 Maleate 64 ARB telmisartan 64 ACIPHEX 64 FULL PRESCRIBING INFORMATION 64 5 FU leucovorin 64 Rasagiline 64 malignant ascites 64 FEMALES SHOULD BE ADVISED 64 receptor modulators 64 Ejection Fraction 64 Percutaneous Tibial Nerve Stimulation 64 Arranon 64 Soriatane 64 danazol 64 Thal Dex 64 Campath alemtuzumab 64 tipifarnib 64 Generalized Anxiety Disorder 64 Antiviral Activity 64 TAXOTERE R 64 fluticasone salmeterol 64 adriamycin 64 lichen planus 64 IFN beta 64 Neulasta ® 64 Phase IIb Clinical Trial 64 Plaquenil 64 Restenosis 64 Omacetaxine 64 Protease Inhibitor 64 DEXILANT 64 Myoblast 64 Cimzia TM 64 Transdermal Delivery 64 adrenal suppression 64 Atypical Antipsychotics 64 Demonstrates Potent 64 Orthostatic Hypotension 64 Nexavar ® 64 Phase 2a Trial 64 Anti VEGF 64 Everolimus 64 immunomodulatory therapy 64 Chronic Myeloid Leukemia 64 pharmacokinetic interactions 64 Cellcept 64 Novel Inhibitor 64 inhalation aerosol 64 Fungal Infections 64 immunomodulatory agents 64 conventional DMARDs 64 PKC# 64 Showed Significant 64 ACTOplus met XR 64 leukotriene receptor antagonists 64 Fabry Disease 64 Abrupt discontinuation 64 vandetanib 64 Genentech Rituxan 64 Enalapril